Parvovirus B19 infection in pediatric oncology patients: Diagnostic value of clinical and serologic parameters compared with nested PCR

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 3, 2009, Pages 173-176

  Soliman, Othman El Sayed ^a   Hegazi Hasan, Moustafa Abd El Aal ^a   El Ashry, Rasha ^a   Zaghloul, Mohammad Hosam Eldeen ^a   Kora, Bothina ^b  

^a MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

^b Mennofiya Faculty of Medicine   (Egypt)

Author keywords

Parvovirus B19; PCR; Pediatric oncology

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS DNA; VIRUS ANTIBODY;

ACUTE LYMPHOCYTIC LEUKEMIA; ANEMIA; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER PATIENT; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA INFECTIOSUM; ERYTHROCYTE TRANSFUSION; FEMALE; HODGKIN DISEASE; HOSPITALIZATION; HUMAN; HUMORAL IMMUNITY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEPHROBLASTOMA; NONHODGKIN LYMPHOMA; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHABDOMYOSARCOMA; SENSITIVITY AND SPECIFICITY; BLOOD; GENETICS; IMMUNE DEFICIENCY; IMMUNOLOGY; NEOPLASM; VIRUS INFECTION;

ANTIBODIES, VIRAL; ANTINEOPLASTIC AGENTS; CHILD, PRESCHOOL; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; NEOPLASMS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; SENSITIVITY AND SPECIFICITY;

EID: 65449152604     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181983b2d     Document Type: Article

References (15)

1. Corcoran A, Doyle S. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol. 2004;53:459-475.
2. Fattet S, Cassinotti P, Popvic MB. Persistent human parvovirus B19 infection in children under maintenance chemotherapy for acute lymphocytic leukemia. J Pediatr Hematol Oncol. 2004;26:497-503.
3. Shaw PJ, Eden T, Cohen BJ. Parvovirus B19 as a cause of chronic anemia in rhabdomyosarcoma. Cancer. 1993;72: 945-949.
4. McNall RY, Head DR, Pui CH, et al. Parvovirus B19 infection in a child with acute lymphoblastic leukemia during induction therapy. J Pediatr Hematol Oncol. 2001;23:309-311.
5. Heegaard ED, Schmiegelow K. Serologic study on B19 infection in childhood acute lymphoblastic leukemia during chemotherapy: clinical and hematologic implications. J Pediatr Hematol Oncol. 2002;24:368-373.
6. Kuo S-H, Lin L-I, Chang C-J, et al. Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy. J Clin Microbiol. 2002;40:3909-3912.
7. Hsu TC, Tsay GJ. Human parvovirus B19 infection in patients with systemic lupus erythematosus. Rheumatology (Oxoford). 2001;40:152-157.
8. El-Mahallawy HA, Mansour T, El-Din SE, et al. Parvovirus B19 infection as a cause of anemia in pediatric acute lymphoblastic leukaemia patients during maintenance chemotherapy. J Pediatr Hematol Oncol. 2004;26:403-406. 9. Us T, Ozune L, Kasifoglu N, et al. The investigation of parvovirus B19 infection in patients with haematological disorders by using PCR and ELISA techniques. Braz J Infect Dis. 2007;11:327-330.
9. Broliden K, Tolfvenstam T, Ohlsson S, et al. Persistent B19 parvovirus infection in pediatric malignancies. Med Pediatr Oncol. 1998;31:66-72.
10. Lindblom A, Heyman M, Gustafsson I, et al. Parvovirus B19 infection in children with acute lymphoblastic leukaemia associated with cytopenia resulting in prolonged interruptions of chemotherapy. Clin Infect Dis. 2008;46:528-536.
11. Flunker G, Peters A, Weirsbitzky S, et al. Persistent parvovirus B19 infection in immunocompromised children. Med Microbiol Immunol. 1998;186:189-194.
12. Zaki Mel S, Hassan SA, Seleim T, et al. Parvovirus B19 infection in children with a variety of haematological disorders. Hematology. 2006;11:261-266.
13. Fujita H, Takada K, Kuremoto K, et al. Human parvovirus B19 infection in patients with hematologic disorders on chemotherapy. Rinsho Ketsueki. 1993;34:28-33.
14. Heegaard ED, Jensen L, Hornsleth A, et al. The role of parvovirus B19 infection in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1999;16:329-334.
15. Chisaka H, Morita E, Yaegashi N, et al. Parvovirus B19 and the pathogenesis of anaemia. Rev Med Virol. 2003;13: 347-359.